Dr Mary Catherine Hertl, MD in Beverly, MA - Medicare Plastic Surgery

Dr Mary Catherine Hertl, MD is a medicare enrolled "Plastic Surgery" physician in Beverly, Massachusetts. Her current practice location is 900 Cummings Ctr, Ste 216t, Beverly, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (978) 969-2081.

Dr Mary Catherine Hertl is licensed to practice in Massachusetts (license number 212487) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1386611630.

Contact Information

	Dr Mary Catherine Hertl, MD
	900 Cummings Ctr, Ste 216t, Beverly, MA 01915-6225
	(978) 969-2081
	(978) 969-2084

Physician's Profile

Full Name	Dr Mary Catherine Hertl
Gender	Female
Speciality	Plastic Surgery
Location	900 Cummings Ctr, Beverly, Massachusetts
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1386611630
Provider Enumeration Date: 03/07/2006
Last Update Date: 07/26/2016

Medicare PECOS Information:

PECOS PAC ID: 0840478293
Enrollment ID: I20171213000487

Medical Identifiers

Medical identifiers for Dr Mary Catherine Hertl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1386611630	NPI	-	NPPES
0183466	Medicaid	MA
212487	Other	MA	TUFTS HEALTH PLAN
J25485	Other	MA	BCBS MA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	212487 (Massachusetts)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mary Catherine Hertl allows following entities to bill medicare on her behalf.

Entity Name	Rush University Medical Center
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1407817257 PECOS PAC ID: 4789679366 Enrollment ID: O20040415000186

News Archive

USPSTF recommends CT screening for people at high risk for lung cancer

Today, in what has been the culmination of more than two decades of research and advocacy, the United States Preventive Services Task Force issued its final recommendation approving CT screening for those at high risk for lung cancer. The recommendation sets the stage for both public and private insurance coverage and is expected to bring about a dramatic increase in lung cancer survival.

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 25th annual conference in San Diego. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

MDMA could help gain trust but does not make one naive find researchers

MDMA or ecstasy pills can help individuals trust more and cooperate say a team of researchers who are looking at its properties that could help treat psychological disorders. The study was published this week in the latest issue of the Journal of Neuroscience.

Wound Management Technologies to market CellerateRx within the U.S.

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today an agreement with the Health Industry Representative Association (HIRA) to serve as a non-exclusive independent sales and marketing representative to market the company's core CellerateRx® product within the U.S.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mary Catherine Hertl is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mary Catherine Hertl, MD 5 Essex Green Dr, Ste 36, Peabody, MA 01960-2921 Ph: (978) 969-2081	Dr Mary Catherine Hertl, MD 900 Cummings Ctr, Ste 216t, Beverly, MA 01915-6225 Ph: (978) 969-2081

News Archive

USPSTF recommends CT screening for people at high risk for lung cancer

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

MDMA could help gain trust but does not make one naive find researchers

Wound Management Technologies to market CellerateRx within the U.S.

Plastic Surgery Doctors in Beverly, MA

Anoush Hadaegh, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 301u, Beverly, MA 01915 Phone: 413-222-2292
Dr. Mahesh Patel, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Suite 105, Beverly, MA 01915 Phone: 978-927-6556
Dr. Jagruti Patel, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Parkhurst Building, Beverly, MA 01915 Phone: 978-927-6556

Dr Mary Catherine Hertl, MD - Medicare Plastic Surgery in Beverly, MA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

USPSTF recommends CT screening for people at high risk for lung cancer

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

MDMA could help gain trust but does not make one naive find researchers

Wound Management Technologies to market CellerateRx within the U.S.

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

USPSTF recommends CT screening for people at high risk for lung cancer

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

MDMA could help gain trust but does not make one naive find researchers

Wound Management Technologies to market CellerateRx within the U.S.

Plastic Surgery Doctors in Beverly, MA